The socio-economic burden of H1-antihistamine-refractory chronic spontaneous urticaria in Germany

被引:3
作者
Augustin, Matthias [1 ]
Beier, Dominik [2 ]
Branner, Jennifer [3 ]
Haeckl, Dennis [4 ]
Hampel, Regina [5 ]
Kramps, Thomas [6 ]
Kurzen, Hjalmar [7 ]
Lintener, Hannah [3 ]
Melzer, Nima [6 ]
Mueller, Malina [3 ]
Staubach, Petra [8 ]
Schwichtenberg, Uwe [9 ]
Termeer, Christian [10 ,11 ]
Zink, Alexander [12 ,13 ]
Nathan, Petra [6 ]
Maurer, Marcus [14 ,15 ,16 ,17 ]
机构
[1] Univ Klinikum Hamburg Eppendorf, IVDP, Hamburg, Germany
[2] InGef Inst Angew Gesundheitsforschung Berlin, Berlin, Germany
[3] WifOR Inst Darmstadt, Darmstadt, Germany
[4] WIG2 Wissenschaftl Inst Gesundheitsokon & Gesundhe, Leipzig, Germany
[5] GKM Therapieforschung Munchen, Munich, Germany
[6] Novartis Pharm GmbH, Nurnberg, Germany
[7] Haut & Laserzentrum Freising, Freising Weihenstephan, Germany
[8] Univ Med Ctr Mainz, Dept Dermatol, Mainz, Germany
[9] Derma Nord Hautarztpraxis Bremen, Bremen, Germany
[10] Practice Trein, Stuttgart, Germany
[11] Univ Freiburg, Dept Dermatol, Freiburg, Germany
[12] Tech Univ Munich, Fak Med, Klin & Poliklin Dermatol & Allergol Biederstein, Munich, Germany
[13] Karolinska Inst, Dept Med Solna, Div Dermatol & Venereol, Stockholm, Sweden
[14] Charite Univ Med Berlin, Inst Allergol, Hindenburgdamm 30, D-12203 Berlin, Germany
[15] Free Univ Berlin, Berlin, Germany
[16] Humboldt Univ, Berlin, Germany
[17] Fraunhofer Inst Translat Med & Pharmacol ITMP Immu, Berlin, Germany
关键词
ECONOMIC BURDEN; PRODUCTIVITY; PSORIASIS; WORK;
D O I
10.1111/jdv.20071
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background and Study Aim: Data from the AWARE study (A Worldwide Antihistamine-Refractory chronic urticaria patient Evaluation) illustrate a substantial disease burden in German patients with H1-antihistamine (-H1-AH)-refractory chronic spontaneous urticaria (CSU). Detrimental effects on patients' quality of life, poor disease control and impairment in the ability to work and perform other daily activities are reported. Based on these findings, this study aims to quantify the epidemiological and socio-economic burden of H1-AH-refractory CSU in Germany. Methods: To determine the epidemiological burden of H1-AH-refractory CSU, the age- and gender-specific prevalence of CSU and the proportion of H1-AH-refractory patients in Germany anonymized data from the InGef research database have been used. In a second step, the socio-economic burden in terms of lost numbers of hours in paid and unpaid work was calculated by extrapolating the age- and gender-specific work productivity and activity impairment (WPAI) observed in AWARE to the H1-AH-refractory CSU population in Germany. Finally, productivity losses in paid and unpaid work were monetized using the human capital and the friction cost approach respectively. Moreover, socio-economic burden was calculated depending on symptom control of the patients (measured by urticaria control test [UCT]). Results: In Germany, over 203,000 patients (20 years or older) had H1-AH-refractory CSU in 2018. The avoided lost paid and unpaid work hours attributable to H1-AH-refractory CSU summed up to over 100 million. Overall, the socio-economic burden of H1-AH-refractory CSU in monetary terms was evaluated at <euro> 2.2 billion and the majority of this was due to unpaid work loss. Patients with poor disease control, as indicated by UCT score < 12, were more likely to suffer from high impairment than patients with controlled disease, resulting in a higher socio-economic burden. Conclusion: The results of our analyses picture the substantial socio-economic burden of H1-AH-refractory CSU and therefore the tremendous impact it has on daily lives of individuals and society overall.
引用
收藏
页码:2102 / 2109
页数:8
相关论文
共 28 条
[1]   Systematic literature review assessing the overall costs and societal impacts of moderate-to-severe atopic dermatitis in Europe [J].
Augustin, M. ;
Misery, L. ;
von Kobyletzski, L. ;
Mealing, S. ;
Redding, M. ;
Chuang, C. C. ;
Massey, R. ;
Cawkwell, M. ;
Bego Le-Bagousse, G. ;
Haddy, L. ;
Rout, R. .
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2022, 36 (12) :2316-2324
[2]   The Impact of Chronic Urticaria from the Patient's Perspective: A Survey in Five European Countries [J].
Balp, Maria-Magdalena ;
Vietri, Jeffrey ;
Tian, Haijun ;
Isherwood, Gina .
PATIENT-PATIENT CENTERED OUTCOMES RESEARCH, 2015, 8 (06) :551-558
[3]   Economic Burden of Psoriasis in the United States A Systematic Review [J].
Brezinski, Elizabeth A. ;
Dhillon, Jaskaran S. ;
Armstrong, April W. .
JAMA DERMATOLOGY, 2015, 151 (06) :651-658
[4]   Methods in health service research - Handling uncertainty in economic evaluations of healthcare interventions [J].
Briggs, AH ;
Gray, AM .
BRITISH MEDICAL JOURNAL, 1999, 319 (7210) :635-638
[5]   Impact of Atopic Dermatitis on Work and Activity Impairment in Taiwan [J].
Chan, Tom C. ;
Lin, Yi-Chun ;
Cho, Yung-Tsu ;
Tang, Chao-Hsiun ;
Chu, Chia-Yu .
ACTA DERMATO-VENEREOLOGICA, 2021, 101
[6]  
GKM gesellschaft fur Therapieforschung mbH, 2022, STAT ANAL
[7]  
Institut fur Arbeitsmarkt- und Berufsforschung (IAB), 2021, SOND IAB ARB WIFOR A
[8]   Impact of chronic urticaria on quality of life and work in Japan: Results of a real-world study [J].
Itakura, Asako ;
Tani, Yumiko ;
Kaneko, Naoko ;
Hide, Michihiro .
JOURNAL OF DERMATOLOGY, 2018, 45 (08) :963-970
[9]   Unpaid work in health economic evaluations [J].
Krol, Marieke ;
Brouwer, Werner .
SOCIAL SCIENCE & MEDICINE, 2015, 144 :127-137
[10]   How to Estimate Productivity Costs in Economic Evaluations [J].
Krol, Marieke ;
Brouwer, Werner .
PHARMACOECONOMICS, 2014, 32 (04) :335-344